Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed)

Archived

National Institutes of Health

Description

This Funding Opportunity Announcement (FOA) solicits grant applications from small business concerns (SBCs) to continue research projects with robustly validated targets for Substance Use Disorders (SUDs). This FOA will provide funding for projects entering at either assay development (AD), lead identification (LI), lead optimization (LO), or preclinical development (PCD) stages to allow for the ultimate goal of successfully completing Investigational New Drug-enabling activities.

Who can apply

  • Small businesses

Contact

NIH OER Webmaster<br/>grantsinfo@nih.gov
grantsinfo@nih.gov

Key dates & funding
  • PostedJul 29, 2021
  • ClosesFeb 18, 2022
  • CFDA93.279
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro